Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Interleukin-1 receptor-associated kinase 4 | ||
Ligand | BDBM639209 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | IRAK4 ADP-Glo Assay | ||
IC50 | 3.50±n/a nM | ||
Citation | Chen, Y; Masuda, E; Lamagna, C BICYCLIC INHIBITORS OF IRAK US Patent US20230391748 Publication Date 12/7/2023 | ||
More Info.: | Get all data from this article, Assay Method | ||
Interleukin-1 receptor-associated kinase 4 | |||
Name: | Interleukin-1 receptor-associated kinase 4 | ||
Synonyms: | IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64 | ||
Type: | Protein | ||
Mol. Mass.: | 51519.08 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q9NWZ3 | ||
Residue: | 460 | ||
Sequence: |
| ||
BDBM639209 | |||
n/a | |||
Name | BDBM639209 | ||
Synonyms: | 4-((cis-3-(dimethylamino)cyclobutyl)ethynyl)-7-isopropoxy-1-(((S)-5-oxopyrrolidin-2-yl)methoxy)isoquinoline-6-carboxamide | US20230391748, Compound I-31 | ||
Type | Small organic molecule | ||
Emp. Form. | C26H32N4O4 | ||
Mol. Mass. | 464.5567 | ||
SMILES | CC(C)Oc1cc2c(OC[C@@H]3CCC(=O)N3)ncc(C#C[C@H]3C[C@H](C3)N(C)C)c2cc1C(N)=O |r,wU:10.9,21.21,23.26,(4.63,4.62,;3.86,3.29,;4.63,1.96,;2.32,3.29,;1.55,1.96,;2.32,.62,;1.55,-.71,;2.32,-2.04,;3.86,-2.04,;4.63,-3.38,;6.17,-3.38,;7.07,-4.62,;8.54,-4.15,;8.54,-2.61,;9.87,-1.84,;7.07,-2.13,;1.55,-3.38,;.01,-3.38,;-.76,-2.04,;-2.3,-2.04,;-3.84,-2.04,;-5.38,-2.04,;-6.47,-3.13,;-7.56,-2.04,;-6.47,-.96,;-9.1,-2.04,;-9.87,-3.38,;-9.87,-.71,;.01,-.71,;-.76,.62,;.01,1.96,;-.76,3.29,;.01,4.62,;-2.3,3.29,)| | ||
Structure |